Clinical trial
The Effects Of Ropinirole On Mood Or Mild Depression In Patients With Moderate…
NCT00357097 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00357097 |
|---|---|
| Title | The Effects Of Ropinirole On Mood Or Mild Depression In Patients With Moderate To Severe Restless Legs Syndrome |
| Official title | A Multicenter 3:1-randomized Placebo-controlled Double-blind Phase IIIb Study on the Effects of Ropinirole on Mood/(Subclinical) Depression in the Therapy of Patients With Moderate to Severe Idiopathic RLS in Germany |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Restless Legs Syndrome, Moderate to Severe Idiopathic Restless Legs Syndrome (RLS) |
| Intervention type | Drug |
| Interventions | Ropinirole |
| Enrollment | 240 |
| Start date | Jun 1, 2006 |
| Primary completion | Dec 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | Jul 27, 2006 |
| Last update posted | Jun 7, 2012 |
| Countries | Germany |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: